Australia's Hydration Pharmaceuticals rises on upbeat sales
** Shares of Hydration Pharmaceuticals Co Ltd HPC.AX as
much as 8.7% to A$0.050, set for best day since May 31, if gains
hold
** Says co has generated $1.7 mln in unaudited net sales
during the first two months of Q2 FY2023, up 31% on last year
** Says sales growth was achieved with ongoing reduction in
group marketing spend
** About 269,250 shares change hand compared to 30-day
average trading volume of 51,919 shares
** Shares of co are down 48.9% YTD as of last close
(Reporting by John Biju in Bengaluru)
((John.Biju@thomsonreuters.com;))
Recent news on Hydration Pharmaceuticals
See all newsBrief: Hydration Pharmaceuticals Launches Pro Rata Entitlement Offer To Raise Up To A$1.43 MLN
Australia's Hydration Pharmaceuticals soars on upbeat monthly sales
Australia's Hydration Pharmaceuticals soars 144% on asset sale to US co
Brief: Hydration Pharmaceuticals Announces Divesture Of Hydralyte's Non-US Assets
Brief: Hydration Pharmaceuticals Says Adem Karafili Appointed Non-Executive Chairman